A functionally defined high-density NRF2 interactome reveals new conditional regulators of ARE transactivation
Autor: | Amy H. Ponsford, James Boyd, Ulrich Stelzl, David J. MacEwan, Nicholas Harper, Christopher M. Sanderson, Erich E. Wanker, Jonathan Woodsmith, Jonathan Poh |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Transcriptional Activation NF-E2-Related Factor 2 Clinical Biochemistry High density Functional impact Computational biology Biology Protein interaction network (PIN) Biochemistry Interactome digestive system environment and public health Fluorescence cross-correlation spectroscopy (FCCS) Cell Line 03 medical and health sciences Transactivation 0302 clinical medicine Humans Drug reaction Transcription factor lcsh:QH301-705.5 lcsh:R5-920 Kelch-Like ECH-Associated Protein 1 Organic Chemistry Dual luminescence-based co-immunoprecipitation (DULIP) respiratory system NFE2L2 KEAP1 Molecular network 030104 developmental biology Gene Expression Regulation lcsh:Biology (General) NRF2/NFE2L2 Human disease network Function and Dysfunction of the Nervous System lcsh:Medicine (General) 030217 neurology & neurosurgery Binary interactome Research Paper |
Zdroj: | Redox Biology, Vol 37, Iss, Pp 101686-(2020) Redox Biology |
ISSN: | 2213-2317 |
Popis: | NRF2 (NFE2L2) is a cytoprotective transcription factor associated with >60 human diseases, adverse drug reactions and therapeutic resistance. To provide insight into the complex regulation of NRF2 responses, 1962 predicted NRF2-partner interactions were systematically tested to generate an experimentally defined high-density human NRF2 interactome. Verification and conditional stratification of 46 new NRF2 partners was achieved by co-immunoprecipitation and the novel integration of quantitative data from dual luminescence-based co-immunoprecipitation (DULIP) assays and live-cell fluorescence cross-correlation spectroscopy (FCCS). The functional impact of new partners was then assessed in genetically edited loss-of-function (NRF2−/−) and disease-related gain-of-function (NRF2T80K and KEAP1−/−) cell-lines. Of the new partners investigated >77% (17/22) modified NRF2 responses, including partners that only exhibited effects under disease-related conditions. This experimentally defined binary NRF2 interactome provides a new vision of the complex molecular networks that govern the modulation and consequence of NRF2 activity in health and disease. Graphical abstract Image 1 Highlights • 1,962 predicted NRF2 partners were tested and 46 new binary partners were identified. • 77% of tested new NRF2 partners modulate ARE-mediated gene expression. • Some novel partners only exhibit functional effects under disease-like conditions. • Quantitative evidence that KEAP1 can modulate ARE-transactivation independently of NRF2. • New NRF2 binding partners reveal 130 novel disease gene associations. |
Databáze: | OpenAIRE |
Externí odkaz: |